TY - STD TI - World Health Organization. Fact sheet No164. http://www.who.int/mediacentre/factsheets/fs164/en/. UR - http://www.who.int/mediacentre/factsheets/fs164/en/ ID - ref1 ER - TY - JOUR AU - Shepard, C. W. AU - Finelli, L. AU - Alter, M. J. PY - 2005 DA - 2005// TI - Global epidemiology of hepatitis C virus infection JO - Lancet Infect Dis VL - 5 UR - https://doi.org/10.1016/S1473-3099(05)70216-4 DO - 10.1016/S1473-3099(05)70216-4 ID - Shepard2005 ER - TY - JOUR AU - McHutchison, J. G. AU - Manns, M. P. AU - Muir, A. J. AU - Terrault, N. A. AU - Jacobson, I. M. AU - Afdhal, N. H. PY - 2010 DA - 2010// TI - Telaprevir for previously treated chronic HCV infection JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0908014 DO - 10.1056/NEJMoa0908014 ID - McHutchison2010 ER - TY - JOUR AU - Poordad, F. AU - McCone, J. AU - Bacon, B. R. AU - Bruno, S. AU - Manns, M. P. AU - Sulkowski, M. S. PY - 2011 DA - 2011// TI - Boceprevir for untreated chronic HCV genotype 1 infection JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1010494 DO - 10.1056/NEJMoa1010494 ID - Poordad2011 ER - TY - STD TI - Hayashi N, Izumi N, Kumada H, Okanoue T, Tsubouchi H, Yatsuhashi H, et al. Simeprevir with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial. J Hepatol. 2014;61:219–27. ID - ref5 ER - TY - JOUR AU - Chayama, K. AU - Takahashi, S. AU - Toyota, J. AU - Karino, Y. AU - Ikeda, K. AU - Ishikawa, H. PY - 2012 DA - 2012// TI - Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders JO - Hepatology VL - 55 UR - https://doi.org/10.1002/hep.24724 DO - 10.1002/hep.24724 ID - Chayama2012 ER - TY - STD TI - Andreone P, Colombo MG, Enejosa JV, Koksal I, Ferenci P, Maieron A, et al. ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97 % and 100 % sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection. Gastroenterology. 2014;147:359–65. e351. ID - ref7 ER - TY - STD TI - Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. ION-2 Investigators, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med. 2014;370:1483–93. ID - ref8 ER - TY - STD TI - Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. ION-1 Investigators, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370:1889–98. ID - ref9 ER - TY - STD TI - Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:657–66. ID - ref10 ER - TY - STD TI - Ginde AA, Scragg R, Schwartz RS, Camargo CA, Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595–603. ID - ref11 ER - TY - STD TI - Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009;30:113–25. ID - ref12 ER - TY - STD TI - Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case–control study. Carcinogenesis. 2008;29:93–9. ID - ref13 ER - TY - STD TI - Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000;11:847–52. ID - ref14 ER - TY - JOUR AU - Ahn, J. AU - Albanes, D. AU - Berndt, S. I. PY - 2009 DA - 2009// TI - Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp055 DO - 10.1093/carcin/bgp055 ID - Ahn2009 ER - TY - STD TI - Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–5. ID - ref16 ER - TY - JOUR AU - Hurst, P. R. AU - Stonehouse, W. AU - Coad, J. PY - 2010 DA - 2010// TI - Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial JO - Br J Nutr VL - 103 UR - https://doi.org/10.1017/S0007114509992017 DO - 10.1017/S0007114509992017 ID - Hurst2010 ER - TY - STD TI - Kozawa K, Imawari M, Shimazu H, Kobori O, Osuga T, Morioka Y. Vitamin D status after total gastrectomy. Dig Dis Sci. 1984;29:411–6. ID - ref18 ER - TY - STD TI - Imawari M, Kozawa K, Akanuma Y, Koizumi S, Itakura H, Kosaka K. Serum 25-hydroxyvitamin D and vitamin D-binding protein levels and mineral metabolism after partial and total gastrectomy. Gastroenterology. 1980;79:255–8. ID - ref19 ER - TY - STD TI - Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51:1158–67. ID - ref20 ER - TY - STD TI - Imawari M, Akanuma Y, Itakura H, Muto Y, Kosaka K, Goodman DS. The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites. J Lab Clin Med. 1979;93:171–80. ID - ref21 ER - TY - STD TI - Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 2011;53:1118–26. ID - ref22 ER - TY - STD TI - Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, et al. Serum 25-hydroxyvitamin D levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. Hepatol Res. 2014;44:1277–85. ID - ref23 ER - TY - JOUR AU - Atsukawa, M. AU - Tsubota, A. AU - Shimada, N. AU - Kondo, C. AU - Itokawa, N. AU - Nakagawa, A. PY - 2014 DA - 2014// TI - Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C JO - Dig Liver Dis VL - 46 UR - https://doi.org/10.1016/j.dld.2014.05.004 DO - 10.1016/j.dld.2014.05.004 ID - Atsukawa2014 ER - TY - JOUR AU - Lagunova, Z. AU - Porojnicu, A. C. AU - Aksnes, L. PY - 2013 DA - 2013// TI - Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial JO - Br J Dermatol VL - 169 UR - https://doi.org/10.1111/bjd.12349 DO - 10.1111/bjd.12349 ID - Lagunova2013 ER - TY - STD TI - Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92:2130–5. ID - ref26 ER - TY - JOUR AU - Holick, M. F. PY - 2007 DA - 2007// TI - Vitamin D, deficiency JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMra070553 DO - 10.1056/NEJMra070553 ID - Holick2007 ER - TY - STD TI - Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53:325–35. ID - ref28 ER - TY - STD TI - Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol. 2000;33:812–7. ID - ref29 ER - TY - STD TI - Yenice N, Gumrah M, Mehtap O, Kozan A, Turkmen S. Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol. 2006;17:260–6. ID - ref30 ER - TY - STD TI - Nessvi S, Johansson L, Jopson J, Stewart A, Reeder A, McKenzie R, et al. Association of 25-hydroxyvitamin D3 levels in adult New Zealanders with ethnicity, skin color and self-reported skin sensitivity to sun exposure. Photochem Photobiol. 2011;87:1173–8. ID - ref31 ER - TY - STD TI - Morel PA, Manolagas SC, Provvedini DM, Wegmann DR, Chiller JM. Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3. J Immunol. 1986;136:2181–6. ID - ref32 ER - TY - JOUR AU - Provvedini, D. M. AU - Deftos, L. J. AU - Manolagas, S. C. PY - 1984 DA - 1984// TI - 1,25-Dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus JO - Biochem Biophys Res Commun VL - 121 UR - https://doi.org/10.1016/0006-291X(84)90719-8 DO - 10.1016/0006-291X(84)90719-8 ID - Provvedini1984 ER - TY - STD TI - Kankova M, Luini W, Pedrazzoni M, Riganti F, Sironi M, Bottazzi B, et al. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology. 1991;73:466–71. ID - ref34 ER - TY - STD TI - von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010;11:344–9. ID - ref35 ER - TY - STD TI - Manuel Quesada J, Solana R, Serrano I, Barrio V, Martinez ME, Santamaria M, et al. Immunologic effects of vitamin D. N Engl J Med. 1989;321:833–4. ID - ref36 ER - TY - JOUR AU - Giulietti, A. AU - Etten, E. AU - Overbergh, L. PY - 2007 DA - 2007// TI - Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory JO - Diabetes Res Clin Pract VL - 77 UR - https://doi.org/10.1016/j.diabres.2006.10.007 DO - 10.1016/j.diabres.2006.10.007 ID - Giulietti2007 ER - TY - STD TI - Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol. 2007;103:558–62. ID - ref38 ER - TY - STD TI - Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod. 2006;75:816–22. ID - ref39 ER - TY - JOUR AU - Nnoaham, K. E. AU - Clarke, A. PY - 2008 DA - 2008// TI - Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis JO - Int J Epidemiol VL - 37 UR - https://doi.org/10.1093/ije/dym247 DO - 10.1093/ije/dym247 ID - Nnoaham2008 ER - TY - JOUR AU - Gal-Tanamy, M. AU - Bachmetov, L. AU - Ravid, A. AU - Koren, R. AU - Erman, A. AU - Tur-Kaspa, R. PY - 2011 DA - 2011// TI - Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes JO - Hepatology VL - 54 UR - https://doi.org/10.1002/hep.24575 DO - 10.1002/hep.24575 ID - Gal-Tanamy2011 ER - TY - STD TI - Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, et al. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology. 2012;56:1231–9. ID - ref42 ER - TY - STD TI - Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E, et al. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. PLoS One. 2013;8:e63672. ID - ref43 ER - TY - STD TI - Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol. 2011;54:887–93. ID - ref44 ER - TY - STD TI - Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int. 2011;24:43–50. ID - ref45 ER - TY - STD TI - Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, et al. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon. 2013;13:e14872. ID - ref46 ER - TY - STD TI - Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology. 2012;56:1641–50. ID - ref47 ER - TY - STD TI - Yokoyama S, Takahashi S, Kawakami Y, Hayes CN, Kohno H, Tsuji K, et al. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial. J Viral Hepat. 2014;21:348–56. ID - ref48 ER - TY - STD TI - Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60:1728–37. ID - ref49 ER - TY - STD TI - Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006;50:640–6. ID - ref50 ER -